Richard J. Kovacs, MD, FACC

Richard Kovacs

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Biomedical Systems(SIGNIFICANT), Jazz Pharmaceuticals(MODEST), Prilenia(MODEST) RESEARCH/RESEARCH GRANTS: Siemens(NONE), Armaron Pharmaceuticcals(NONE) OTHER FINANCIAL BENEFIT: Cook Incorporated -Med Institute(SIGNIFICANT)

View Full Disclosure

This site uses cookies to improve your experience.

By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Service.